Literature DB >> 24706253

[Sclerotization of orbital lymphangioma with OK-432].

W Lagrèze1, M Metzger, J Rössler.   

Abstract

Orbital lymphangiomas are mostly congenital, apparent vascular space-occupying lesions, which can lead to disfiguring swelling of the periorbital soft tissues, ocular motility disorders, optic nerve compression and keratopathy. The treatment is challenging because the disease is principally incurable. Lymphangiomatous tissue can be surgically partially reduced or treated by intralesional injection of various sclerosants. In this review we report the successful use of OK-432 for destruction of a macrocystic orbital lymphangioma.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24706253     DOI： 10.1007/s00347-014-3046-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  11 in total

1.  Development. Lymphatics make the break.

Authors:  Rakesh K Jain; Timothy P Padera
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

2.  Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.

Authors:  Robert H Hill; William E Shiels; Jill A Foster; Craig N Czyz; Andrew Stacey; Kelly R Everman; Kenneth V Cahill
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Mar-Apr       Impact factor: 1.746

3.  Orbital lymphangioma: an analysis of 26 patients.

Authors:  M Tunç; E Sadri; D H Char
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

Review 4.  Orbital lymphangiomas: a review of management strategies.

Authors:  Konal Saha; Brian Leatherbarrow
Journal:  Curr Opin Ophthalmol       Date:  2012-09       Impact factor: 3.761

5.  Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.

Authors:  Robert M Schwarcz; Guy J Ben Simon; Todd Cook; Robert A Goldberg
Journal:  Am J Ophthalmol       Date:  2006-02       Impact factor: 5.258

Review 6.  Head and neck lymphatic malformation treatment: a systematic review.

Authors:  Mary Theresa Adams; Babette Saltzman; Jonathan A Perkins
Journal:  Otolaryngol Head Neck Surg       Date:  2012-07-11       Impact factor: 3.497

Review 7.  New treatment options for lymphangioma in infants and children.

Authors:  Chantal M Giguère; Nancy M Bauman; Richard J H Smith
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-12       Impact factor: 1.547

8.  Orbital-adnexal lymphangiomas. A spectrum of hemodynamically isolated vascular hamartomas.

Authors:  J Rootman; E Hay; D Graeb; R Miller
Journal:  Ophthalmology       Date:  1986-12       Impact factor: 12.079

Review 9.  Pathogenesis of lymphangiomas.

Authors:  Susanne Wiegand; Behfar Eivazi; Peter J Barth; Dirk Berens von Rautenfeld; Benedikt J Folz; Robert Mandic; Jochen A Werner
Journal:  Virchows Arch       Date:  2008-05-24       Impact factor: 4.064

Review 10.  Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature.

Authors:  Michelle T Poldervaart; Corstiaan C Breugem; Lucienne Speleman; Suzanne Pasmans
Journal:  J Craniofac Surg       Date:  2009-07       Impact factor: 1.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.